Meuth, Sven G.; Wolff, Stephanie; Mueck, Anna et al.
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or OfatumumabANNALS OF NEUROLOGY. Bd. 97. H. 3. 2024 S. 583-595
Poppe, Jonas; Boesmans, Leen; Vieira-Silva, Sara et al.
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an <i>in vitro</i> analysisGUT MICROBES. Bd. 16. H. 1. 2024
Becker, Jan; Schöne, Klaus; Beutel, Till et al.
Digitale Unterstützung der Gefährdungsbeurteilung – Pilotstudie an Schulen in Rheinland-PfalzASU. Bd. 59. H. 01. 2024 S. 47-55
Kuhlen, Michaela; Schaller, Tina; Dintner, Sebastian et al.
Double Heterozygous Pathogenic Variants in <i>TP53</i> and <i>CHEK2</i> in Boy with Undifferentiated Embryonal Sarcoma of the LiverINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 25. H. 21. 2024
Rodrigo, Maria Belen; De Min, Anna; Jorch, Selina Kathleen et al.
Dual fluorescence reporter mice for Ccl3 transcription, translation, and intercellular communicationJOURNAL OF EXPERIMENTAL MEDICINE. Bd. 221. H. 7. 2024
Sallbach, J.; Vilar, J. B.; Rasenberger, B. et al.
DUSP1 mediates glioblastoma resistance to temozolomide <i>via</i> inhibition of senescence inductionNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 397. 2024 S. S15-S15
Caenepeel, Clara; Falony, Gwen; Machiels, Kathleen et al.
Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel DiseaseGASTROENTEROLOGY. Bd. 166. H. 3. 2024 S. 483-495
Echchannaoui, Hakim; Perreau, Matthieu; Schild, Hansjoerg et al.
Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapyFRONTIERS IN IMMUNOLOGY. Bd. 15. 2024
Welte-Jzyk, Claudia; Pluemer, Vera; Schumann, Sven et al.
Effect of the antirheumatic medication methotrexate (MTX) on biomechanical compressed human periodontal ligament fibroblasts (hPDLFs)BMC ORAL HEALTH. Bd. 24. H. 1. 2024
Sens-Albert, Carla; Weisenburger, Sabrina; Koenig, Beatrix C. et al.
Effects of a proprietary mixture of extracts from <i>Sabal serrulata</i> fruits and <i>Urtica dioica</i> roots (WS® 1541) on prostate hyperplasia and inflammation in rats and human cellsFRONTIERS IN PHARMACOLOGY. Bd. 15. 2024